Cargando…

A framework for assessing the risk of resistance for antimalarials in development

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Ding, Xavier C, Ubben, David, Wells, Timothy NC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472671/ http://dx.doi.org/10.1186/1475-2875-11-S1-P23

Ejemplares similares

A framework for assessing the risk of resistance for anti-malarials in development
por: Ding, Xavier C, et al.
Publicado: (2012)

Aspidosperma species (Apocynaceae) as sources of antimalarials: from the in vitro antiplasmodial activity of extracts to pre-clinical toxicological studies for the development of efficient and safe antimalarial phytomedicines
por: Braga de Oliveira, Alaide, et al.
Publicado: (2014)

Antimalarial drugs: unexpected evolutionary consequences
por: Schneider, Petra, et al.
Publicado: (2010)

The role of antimalarials in lupus nephritis: a review
por: Lee, Senq-J, et al.
Publicado: (2012)

Discovering antimalarials with a differential mode of action
por: Sanz, Laura, et al.
Publicado: (2014)

Large differences in variability for genes associated with antimalarial drug resistance between samples from Tanzania and Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2014)

Collaborative approaches for Target ID in neglected diseases: identifying new antimalarial targets
por: Lafuente, Maria Jose, et al.
Publicado: (2014)

Antimalarial treatment by health care providers in Port Harcourt, Nigeria
por: Ebong, Omotavo O, et al.
Publicado: (2012)

Mechanistic insights into non-immunosuppressive immunophilin ligands as potential antimalarial therapeutics
por: Yoon, Ho Sup, et al.
Publicado: (2010)

The global challenge of antimalarial drug resistance
por: Ringwald, Pascal, et al.
Publicado: (2012)

Optimal dose finding for novel antimalarial combination therapy*
por: Duparc, S, et al.
Publicado: (2012)

In-vitro studies on the sensitivity pattern of Plasmodium falciparum to antimalarial drugs and local herbal extracts
por: Olasehinde, Grace, et al.
Publicado: (2012)

Differences in the pharmacokinetics of currently approved antimalarial drugs in uncomplicated malaria patients compared to healthy subjects
por: Jain, Jay Prakash, et al.
Publicado: (2012)

A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the antimalarial agents KAE609 and piperaquine (PPQ)
por: Stein, Daniel S, et al.
Publicado: (2014)

Antimalarial drug discovery – the path towards eradication
por: BURROWS, JEREMY N, et al.
Publicado: (2014)

A systematic review of published antimalarial clinical trials: parasite clearance of artemisinin-containing regimens in the treatment of uncomplicated malaria
por: Das, Debashish, et al.
Publicado: (2012)

New drugs for the control and elimination of malaria: a snapshot of the pipeline
por: Wells, Timothy NC
Publicado: (2012)

Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence “transmission blocking” assay
por: Lelièvre, Joël, et al.
Publicado: (2012)

Progress in the development of Reversed Chloroquine molecules as antimalarial therapy
por: Burgess, Steven J, et al.
Publicado: (2010)

Antimalarial market composition and performance in Nigeria and the Democratic Republic of Congo: results from 2013 ACTwatch outlet surveys
por: Littrell, Megan, et al.
Publicado: (2014)

Scoliosis from the perspective of a fifteen year old
por: Byskosh, NC
Publicado: (2013)

Developing a framework for replication of research in implementation science
por: Curran, Janet, et al.
Publicado: (2014)

Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of the 6-oxopurine phosphoribosyltransferases and have antimalarial activity
por: Keough, Dianne, et al.
Publicado: (2014)

Testing of the WHO hand hygiene self-assessment framework
por: Stewardson, AJ, et al.
Publicado: (2011)

Structural analysis of mitochondrial cytochrome bc(1) complex with atovaquone bound reveals the molecular basis of antimalarial drug action
por: Birth, Dominic, et al.
Publicado: (2014)

Developing a global core competency framework for clinical research
por: Furtado, Tamzin, et al.
Publicado: (2015)

A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate
por: Docteur, Elizabeth, et al.
Publicado: (2015)

A framework for the development and appraisal of diet and eating behaviour outcome measures
por: Ward, Dianne, et al.
Publicado: (2013)

Assessment of a probabilistic framework for combining structure- and ligand-based virtual screening
por: Fulle, Simone, et al.
Publicado: (2012)

Use of the WHO hand hygiene self-assessment framework tool in Dutch hospitals
por: Voss, A, et al.
Publicado: (2011)

New medicines to improve control and contribute to the eradication of malaria
por: Wells, Timothy NC
Publicado: (2010)

Risk factors for the development of carbapenem-resistant Klebsiella pneumoniae infections in critically ill patients
por: Vardakas, KZ, et al.
Publicado: (2010)

A framework to assess the added value of subgroup analyses when the overall treatment effect (TE) was significant
por: Sun, Hong, et al.
Publicado: (2013)

Development of an ecological framework for building successful collaboration between Primary Care and Public Health
por: Valaitis, Ruta, et al.
Publicado: (2014)

Left ventricular remodeling following myocardial infarction revealed with a quantitative diffusion MRI tractography framework
por: Mekkaoui, Choukri, et al.
Publicado: (2012)

Coactivation of estrogen receptor alpha by the DEAD-box RNA helicases p68 and p72 and its role in breast cancer
por: Fuller-Pace, FV, et al.
Publicado: (2008)

Comparison of microscopic, phenotypic and molecular techniques for the rapid identification and susceptibility testing of Staphylococci from positive blood culture bottles
por: Shah, A, et al.
Publicado: (2009)

P129: Experience of medical research institute (MRI) in applying WHO hand hygiene self assessment framework
por: Eldeeb, M, et al.
Publicado: (2013)

P01-05 Development of the MOVING policy framework: monitoring and promoting action in physical activity policy
por: Oldridge-Turner, Kate, et al.
Publicado: (2022)

PARADOCKS – a framework for molecular docking
por: Pippel, M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_k1cbp1kh9fsebjc02tob3m3g80